Maria-Victoria Mateos-Manteca

141PUBLICATIONS
559CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical mycologyHaematological tumoursNuclear physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (141)

|Sep 02, 2026
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.

|Aug 06, 2026
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study.

|Jul 31, 2026
High-Risk Smoldering Multiple Myeloma: A Review of Controversies in Early Treatment Versus Observation.

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

Pageof 24

Frequent Collaborators

48 joint publications

Jesús San-Miguel Izquierdo

38 joint publications

Bruno Paiva

30 joint publications

JuanJose Lahuerta Palacios

28 joint publications

Laura Rosiñol